Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

139: Ex Vivo and In Vivo Generation of Dual Specific CAR T Cells for Combination CAR T/Oncolytic Virus Therapy

Disclosures:  R.G. Vile: None.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.